CEO Angel Stanz Email #5 *Unable to make the ph
Post# of 5949
Posted On: 04/25/2014 9:03:48 AM
CEO Angel Stanz Email #5
*Unable to make the phone call, Angel took the time to answer the questions I had (Email #4 reference).
On Jun 22, 2012, at 8:44 AM, BN wrote:
> Angel,
>
> My apologies, but something has come up.
> I will be unavailable until after July 5th.
>
> Best,
> BN
.......................
From: (Angel) BG MedTech <angel@bgmedtech.com>
To: ********************.com>
Sent: Friday, June 22, 2012 1:32 PM
Subject: Re: Thank You!
BN,
No problem. Please reach out to me when you return.
In the meantime, I answered some similar questions recently. I thought this could be a quick response that I could copy to you that would address some of the questions. Although, you have brought up some additional topics that I would also be open to addressing with you.
Please see below.
####
The .000x prices are perhaps annoying, but we view them as temporary fluctuations. Many stocks move daily through the entire range of values RIGH has moved in the past 6 months. Of course, at the current auth shares and price points there can be resistance between key levels. However, the daily PPS does not overshadow our primary agenda of technology and marketshare growth. Consistent growth will reflect upon the PPS in due time.
Planned corrective measures are:
- Additional publicity through major media (print, video, web)
- Additional publicity through minor media (blog)
- Further definition of the revenue models and release schedule for products shown upon the BG Med Tech website.
- Further definition of products in development not shown upon the BG Med Tech website.
- Clarification on BGMT's expansion into alternative wellness technologies, that carry the company beyond cannabis medicine.
- Completing expansions into regional territories (this brings localized publicity & press)
- Uplisting to the QB exchange, and off the Pink Sheet exchange (builds investor confidence)
... and of course, financial details, and name change.
This is a PR issue far more than it is an IR issue. Additional investors need to be introduced to the opportunity. By this of course I mean truly interested shareholders, not small cap marketing campaigns. Such tactics are not of interest to us. We're here to build genuine interest.
These corrective measures are in progress. Our course has been unwavering since the reverse merger. We must also be careful in our rollout of information. Many eyes are upon us, especially those of our competitors. Many covet what we are able to do. Wherever possible, we look to be way out in front before revealing our directions. To do anything less would do a disservice to further profit generation, and thusly, PPS. Yet, we seek to be as transparent to our shareholders as we can. It is a delicate balance.
There are multifaceted purposes in each of our press releases. They are building a story and revealing a path that will be become clearer in hindsight.
There is much more to come.
####
Warm Regards,
Angel Stanz, CEO
BG Medical Technologies, Inc.
RightSmile, Inc.
********************
*Unable to make the phone call, Angel took the time to answer the questions I had (Email #4 reference).
On Jun 22, 2012, at 8:44 AM, BN wrote:
> Angel,
>
> My apologies, but something has come up.
> I will be unavailable until after July 5th.
>
> Best,
> BN
.......................
From: (Angel) BG MedTech <angel@bgmedtech.com>
To: ********************.com>
Sent: Friday, June 22, 2012 1:32 PM
Subject: Re: Thank You!
BN,
No problem. Please reach out to me when you return.
In the meantime, I answered some similar questions recently. I thought this could be a quick response that I could copy to you that would address some of the questions. Although, you have brought up some additional topics that I would also be open to addressing with you.
Please see below.
####
The .000x prices are perhaps annoying, but we view them as temporary fluctuations. Many stocks move daily through the entire range of values RIGH has moved in the past 6 months. Of course, at the current auth shares and price points there can be resistance between key levels. However, the daily PPS does not overshadow our primary agenda of technology and marketshare growth. Consistent growth will reflect upon the PPS in due time.
Planned corrective measures are:
- Additional publicity through major media (print, video, web)
- Additional publicity through minor media (blog)
- Further definition of the revenue models and release schedule for products shown upon the BG Med Tech website.
- Further definition of products in development not shown upon the BG Med Tech website.
- Clarification on BGMT's expansion into alternative wellness technologies, that carry the company beyond cannabis medicine.
- Completing expansions into regional territories (this brings localized publicity & press)
- Uplisting to the QB exchange, and off the Pink Sheet exchange (builds investor confidence)
... and of course, financial details, and name change.
This is a PR issue far more than it is an IR issue. Additional investors need to be introduced to the opportunity. By this of course I mean truly interested shareholders, not small cap marketing campaigns. Such tactics are not of interest to us. We're here to build genuine interest.
These corrective measures are in progress. Our course has been unwavering since the reverse merger. We must also be careful in our rollout of information. Many eyes are upon us, especially those of our competitors. Many covet what we are able to do. Wherever possible, we look to be way out in front before revealing our directions. To do anything less would do a disservice to further profit generation, and thusly, PPS. Yet, we seek to be as transparent to our shareholders as we can. It is a delicate balance.
There are multifaceted purposes in each of our press releases. They are building a story and revealing a path that will be become clearer in hindsight.
There is much more to come.
####
Warm Regards,
Angel Stanz, CEO
BG Medical Technologies, Inc.
RightSmile, Inc.
********************
(0)
(0)